Le Lézard
Classified in: Health, Science and technology
Subject: TRADE SHOWS/SEMINARS/WEBINARS

HealthGrid to Showcase its Full Suite Patient Engagement Platform at Centricity Live 2017


ORLANDO, FL--(Marketwired - May 10, 2017) - HealthGrid, a mobile patient engagement leader and Centricitytm partner, will be exhibiting its patient engagement platform at the Centricity Live 2017 conference May 17-20 in Boston, Mass., showcasing its solutions and how its platform delivers at least an 8:1 ROI for GE Centricity customers.

"We are excited to participate in the Centricity Live conference and demonstrate how our platform has helped GE Centricity customers, such as Diagnostic Clinic Medical Group, Florida Cancer Specialists, ColumbiaDoctors and other clients that include over 1,000 providers, realize success in creating a truly consistent patient engagement experience," said Raj Toleti, CEO and Co-Founder of HealthGrid. "We are looking forward to sharing those success stories with everyone at Centricity Live and helping more GE Healthcare customers experience success with HealthGrid."

HealthGrid simplifies care throughout the continuum with their suite of products including, CareNotifytm and CareNarrative,tm which gives health systems and providers a powerful CRM platform allowing physicians to connect with their patients anytime, anywhere, and through any mobile device, to provide actionable care coordination, access to critical health information, and to enable self-care management.

"HealthGrid has been a valuable team mate, facilitating the implementation of innovative yet practical solutions that have improved care delivery and the management of our patients," said Dr. James Rivenbark, President of Diagnostic Clinic Medical Group. "Using the suite of HealthGrid products has produced measurable results, increasing patient satisfaction and organizational efficiency."

HealthGrid offers the first patient engagement platform to help providers activate, acquire and retain patients while simultaneously complying with demanding regulatory requirements such as Meaningful Use and Medicare's Merit-Based Incentive Payment System (MIPS).

HealthGrid affords GE Healthcare and other customers the ability to seamlessly connect with patients throughout the continuum of care with:

"The Centricity Live conference is a great way for potential customers to see first-hand how HealthGrid can simplify and improve their process to connect with patients at anytime, anywhere and on any device," Toleti said.

About HealthGrid
HealthGrid is shifting the patient experience paradigm -- meeting patients where they are. Our mobile-first CRM platform is the industry leading patient engagement solution that enables providers to engage and activate patients at any point in the care continuum. For more information, visit www.healthgrid.com or connect on Twitter, Facebook, or Linkedin.


These press releases may also interest you

at 18:05
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

at 14:06
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...

at 14:05
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

at 13:27
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

at 11:03
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...

at 08:35
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...



News published on and distributed by: